Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122688052 | 12268805 | 2 | F | 20160312 | 20160629 | 20160414 | 20160706 | EXP | FR-ASTRAZENECA-2016SE37513 | ASTRAZENECA | 23666.00 | DY | F | Y | 0.00000 | 20160707 | MD | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122688052 | 12268805 | 1 | PS | INEXIUM | ESOMEPRAZOLE | 1 | Oral | Y | 21153 | 40 | MG | QD | |||||||
| 122688052 | 12268805 | 2 | SS | INEXIUM | ESOMEPRAZOLE | 1 | Oral | Y | 21153 | ||||||||||
| 122688052 | 12268805 | 3 | SS | EMEND | APREPITANT | 1 | Oral | 320 | MG | Y | 0 | 80 | MG | QD | |||||
| 122688052 | 12268805 | 4 | SS | LEVACT | BENDAMUSTINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | 374 | MG | 0 | 187 | MG | QD | ||||||
| 122688052 | 12268805 | 5 | SS | CYTARABINE. | CYTARABINE | 1 | Intravenous (not otherwise specified) | 0 | 312 | MG | QD | ||||||||
| 122688052 | 12268805 | 6 | SS | ETOPOSIDE. | ETOPOSIDE | 1 | Intravenous (not otherwise specified) | 310.0MG ONCE/SINGLE ADMINISTRATION | 310 | MG | 0 | 310 | MG | ||||||
| 122688052 | 12268805 | 7 | SS | ZOPHREN | ONDANSETRON | 1 | Intravenous (not otherwise specified) | 64 | MG | Y | 0 | 8 | MG | BID | |||||
| 122688052 | 12268805 | 8 | C | FLECAINE | FLECAINIDE | 1 | 0 | ||||||||||||
| 122688052 | 12268805 | 9 | C | SECTRAL | ACEBUTOLOL HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 122688052 | 12268805 | 10 | C | ZELITREX | VALACYCLOVIR HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 122688052 | 12268805 | 11 | C | ELUDRIL | CHLORHEXIDINE GLUCONATECHLOROBUTANOL | 1 | 0 | ||||||||||||
| 122688052 | 12268805 | 12 | C | AMPHOTERICINE B | AMPHOTERICIN B | 1 | 0 | ||||||||||||
| 122688052 | 12268805 | 13 | C | CHIBRO-CADRON | DEXAMETHASONENEOMYCIN SULFATE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122688052 | 12268805 | 4 | Adult T-cell lymphoma/leukaemia |
| 122688052 | 12268805 | 5 | Adult T-cell lymphoma/leukaemia |
| 122688052 | 12268805 | 6 | Adult T-cell lymphoma/leukaemia |
| 122688052 | 12268805 | 8 | Tachycardia |
| 122688052 | 12268805 | 9 | Tachycardia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122688052 | 12268805 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122688052 | 12268805 | Acute kidney injury | |
| 122688052 | 12268805 | Proteinuria |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122688052 | 12268805 | 1 | 20160308 | 0 | ||
| 122688052 | 12268805 | 3 | 20160309 | 20160312 | 0 | |
| 122688052 | 12268805 | 4 | 20160309 | 20160310 | 0 | |
| 122688052 | 12268805 | 6 | 20160311 | 20160311 | 0 | |
| 122688052 | 12268805 | 7 | 20160309 | 20160313 | 0 | |
| 122688052 | 12268805 | 8 | 20160313 | 0 | ||
| 122688052 | 12268805 | 9 | 20160313 | 0 | ||
| 122688052 | 12268805 | 11 | 20160308 | 0 | ||
| 122688052 | 12268805 | 12 | 20160308 | 0 | ||
| 122688052 | 12268805 | 13 | 20160308 | 0 |